Tag: Oncology

Merrimack Pharmaceuticals is set to dissolve after receiving a $225 million payment for FDA approval. Shareholders will receive a dividend ...

Accuray's strategic move into emerging markets, including China and India, is expected to bolster its growth outlook and attract investor ...

Regeneron Pharmaceuticals, a leading biopharmaceutical company, is gaining recognition for its innovative approach and strong financial performance. With a diverse ...

Tango Therapeutics receives positive coverage from Piper Sandler, emphasizing its strong position in precision oncology. The firm believes the company's ...

Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...

Oppenheimer lowers price target on Gilead Sciences after Q4 earnings report and challenges in drug pipeline. Optimistic about prospects for ...

Learn how artificial intelligence is revolutionizing cancer detection and treatment. Discover the advantages and potential impact of this groundbreaking technology. ...

Johnson & Johnson's acquisition of Ambrx showcases the power of biotech M&A, rewarding investors with staggering returns and highlighting the ...

Johnson & Johnson's $2 billion acquisition of Ambrx Biopharma emphasizes its focus on oncology and targeted cancer treatments. #PharmaNews

Taiho Ventures increases investment pool to $400M, reinforcing commitment to supporting innovative biotech start-ups in drug discovery. #Taiho #biotech #innovation